A comparison of buprenorphine (cas 136232-82-1) and psychosocial treatment outcomes in psychosocial and medical settings
-
Add time:09/05/2019 Source:sciencedirect.com
BackgroundFacing an epidemic of opioid-related mortality, many government health departments, insurers, and treatment providers have attempted to expand patient access to buprenorphine (cas 136232-82-1) in psychosocial substance use disorder (SUD) programs and medical settings.
We also recommend Trading Suppliers and Manufacturers of buprenorphine (cas 136232-82-1). Pls Click Website Link as below: cas 136232-82-1 suppliers
Prev:Review articleTransdermal buprenorphine (cas 136232-82-1) patch: Potential for role in management of opioid dependence
Next:Epidemiology of severe buprenorphine (cas 136232-82-1) exposures reported to the U.S. Poison Centers) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Short CommunicationPerceived need and availability of psychosocial interventions across buprenorphine (cas 136232-82-1) prescriber specialties09/07/2019
- Epidemiology of severe buprenorphine (cas 136232-82-1) exposures reported to the U.S. Poison Centers09/06/2019
- Review articleTransdermal buprenorphine (cas 136232-82-1) patch: Potential for role in management of opioid dependence09/04/2019
- Research Paper“They're making it so hard for people to get help:” Motivations for non-prescribed buprenorphine (cas 136232-82-1) use in a time of treatment expansion09/03/2019
- Evaluation of an emergency department buprenorphine (cas 136232-82-1) induction and medication-assisted treatment referral program09/02/2019
- Full length articleUnderstanding the use of diverted buprenorphine (cas 136232-82-1)09/01/2019
- Effects of ascending buprenorphine (cas 136232-82-1) doses on measures of experimental pain: A pilot study08/31/2019
- buprenorphine (cas 136232-82-1) in the United States: Motives for abuse, misuse, and diversion08/30/2019
- Full length articleMaternal buprenorphine (cas 136232-82-1) treatment during pregnancy and maternal physiology08/29/2019
